Prevest Denpro (PREVEST) | Stock Overview & Key Data
Prevest Denpro Performance Comparison
Stock Range
Today's Range
Low: ₹545.00
High: ₹559.00
on August 12, 2025
52 Week Range
Low: ₹393.60
High: ₹686.00
on March 17, 2025
on January 13, 2025
All-Time High: ₹686.00 on January 13, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR6.7B
EPS
15.14
P/E Ratio (TTM)
36.86
Forward P/E
N/A
P/B Ratio
6.35
PEG Ratio
N/A
Div. Yield
N/A
ROE
18.70%
Beta
0.505
Debt to Equity
0.00
Financial Highlights
Profitability
Gross Margin
86.70%
Operating Margin
32.92%
Profit Margin
28.81%
Returns and Earnings
Return on Assets (TTM)
12.17%
Return on Equity (TTM)
18.70%
EBITDA
INR261.5M
Net Income (TTM)
INR181.6M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR52.51
Quarterly Revenue Growth (YoY)
13.70%
Quarterly Earnings Growth (YoY)
7.70%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Prevest Denpro PREVEST | 6.70B Small-cap | 1.45% | 3.87% | 15.53% | 14.34% | -7.00% | 3.30% | 65.82% | 110.57% |
| Poly Medicure POLYMED | 195.30B Mid-cap | -1.51% | -11.04% | -20.44% | -12.40% | -26.34% | 1.13% | 163.79% | 358.72% |
| Dr Agarwal's Health AGARWALEYE | 140.42B Mid-cap | -2.02% | 4.44% | 21.23% | 9.67% | 11.09% | 10.98% | 10.98% | 10.98% |
| Laxmi Dental LAXMIDENTL | 21.85B Small-cap | -7.78% | -8.76% | -0.56% | -10.10% | -28.88% | -23.84% | -23.84% | -23.84% |
| Tarsons Products TARSONS | 19.89B Small-cap | -0.35% | -2.02% | -0.03% | 5.28% | -7.84% | -11.67% | -50.13% | -54.33% |
| Centennial Surgical CSURGSU | 558.19M Small-cap | 5.12% | -1.90% | 24.05% | 14.39% | 13.97% | 40.78% | 192.45% | 272.15% |
Ownership & Short Interest
Insider Ownership
78.37%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
5K
Average 90-Day Volume
12K
Prevest Denpro Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Prevest Denpro would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is PREVEST's 52-week high and low?
- In the last 52 weeks, Prevest Denpro reached a high of ₹686.00 (on January 13, 2025) and a low of ₹393.60 (on March 17, 2025).
- What is the market cap and P/E ratio for PREVEST?
- Curious about Prevest Denpro's size and valuation? Its market capitalization stands at 6.70B. When it comes to valuation, the P/E ratio (trailing twelve months) is 36.86, and the forward P/E (looking ahead) is N/A.
- Does PREVEST pay dividends? If so, what's the yield?
- As for dividends, Prevest Denpro isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Prevest Denpro's main competitors or similar companies to consider before investing?
When looking at Prevest Denpro, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Poly Medicure
POLYMED195.30B Healthcare Medical Instruments & Supplies 1.13% 163.79% Dr Agarwal's Health
AGARWALEYE140.42B Healthcare Medical Instruments & Supplies 10.98% 10.98% Laxmi Dental
LAXMIDENTL21.85B Healthcare Medical Instruments & Supplies -23.84% -23.84% Tarsons Products
TARSONS19.89B Healthcare Medical Instruments & Supplies -11.67% -50.13% Centennial Surgical
CSURGSU558.19M Healthcare Medical Instruments & Supplies 40.78% 192.45% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Prevest Denpro Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Prevest Denpro's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 18.70%, the Debt to Equity ratio from the most recent quarter is 0.00, and its Gross Profit Margin stands at 86.70%.
- What is the recent revenue and earnings growth for PREVEST?
- Looking at Prevest Denpro's growth, its revenue over the trailing twelve months (TTM) was INR630M. Compared to the same quarter last year (YoY), quarterly revenue grew by 13.70%, and quarterly earnings saw a YoY growth of 7.70%.
- How much of PREVEST stock is held by insiders and institutions?
- Wondering who owns Prevest Denpro stock? Company insiders (like executives and directors) hold about 78.37% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.